studies on absorption , plasma concentrations and excretion with ( +/- ) isopropyl-2-methoxyethyl-1,4-dihydro-2,6-dimethyl-4- ( 3-nitrophenyl ) -3,5-pyridinedicarboxylate ( nimodipine , bay e 9736 , nimotop ) have been conducted in rat , dog and monkey using the carbon-14-labelled substance and a wide range of doses ( 0.05-10 mg/kg ) administered via different routes ( intravenous , oral , intraduodenal ) .
C0028094
nimodipine
C0678207
nimotop